![Curtis Head](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Curtis Head
No más puestos en curso
Historial de carrera de Curtis Head
Antiguos cargos conocidos de Curtis Head.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Relevare Pharmaceuticals Ltd.
![]() Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Director Técnico/Científico/I+D | 18/08/2011 | - |
The University of California, San Francisco | Corporate Officer/Principal | 01/01/1996 | - |
Relevare Aust Pty Ltd.
![]() Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia. | Corporate Officer/Principal | 24/05/2010 | - |
Formación de Curtis Head.
San Francisco State University | Undergraduate Degree |
Estadísticas
Internacional
Australia | 3 |
Estados Unidos | 3 |
Operativa
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Relevare Aust Pty Ltd.
![]() Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia. | Health Technology |
Relevare Pharmaceuticals Ltd.
![]() Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Curtis Head
- Experiencia